comparemela.com

Latest Breaking News On - Shaheen lakhan - Page 7 : comparemela.com

Quick, Affordable Test Helps Predict CGRP Response for Migraine

Testing for nonictal cephalic allodynia can help determine with high accuracy which migraine patients will (and which will not) respond to treatment with the anti-CGRP agent galcanezumab.

United statesSait ashinaEli lillyShaheen lakhanBeth israel deaconess medical centerHarvard medical schoolQuantitative sensory testingRami bursteinTrial and error prescribingMedscape medical newsMigraine headacheEadache migrainePain managementPain managementAcute painNerve cell

Novel Tool Empowers Patients to Resolve Vertigo on Their Own

An online tool can help patients diagnosis and treat an episode of recurrent benign paroxysmal positional vertigo on their own.

United statesSoult ukpyolsiSouth koreaJi soo kimShaheen lakhanHyo jung kimSeoul national university in koreaDepartment of neurologySeoul national universityMedscape medical newsHealthcare and medical technologyEalth and medical techEalth and med techEalth and medical technologyNt earsBenign positional vertigo

Can you actually boost serotonin?

The feel good neurotransmitter serotonin is associated with mood.

United statesTeresa poprawskiShaheen lakhanRelief mental healthLive science

Click Therapeutics Shares 2022 Accomplishments and Development Progress in its Prescription Digital Therapeutics Programs

Click Therapeutics Shares 2022 Accomplishments and Development Progress in its Prescription Digital Therapeutics Programs
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesDaniel busbyCathleen plattShaheen lakhanDigital working alliancePsych congressDrug administrationClick therapeutics incBoehringer ingelheimNeuroscience education instituteInformation technology in medicine awardMassachusetts medical societyDigital therapeuticsDigital neuro activationClinical operationsVice president

Click Therapeutics wins breakthrough nod for PDT for migraines

Click Therapeutics announced that it received FDA breakthrough device designation for its CT-132 prescription digital therapeutic (PDT).

Austin speierShaheen lakhanStewart tepperGeisel school of medicine at dartmouthDartmouth headache centerClick therapeuticsYork based clickClick neurobehavioral interventionGeisel schoolDartmouth headache

vimarsana © 2020. All Rights Reserved.